BackNatraj Proteins Limited Overview

Natraj Proteins Limited EBIT

Latest ebit for NATRAJPR.BO: $67M, below the sector sector average of $2.5T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$26.98M
↑ 512.22% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

$66.95M
↑ 425.65% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Natraj Proteins Limited (NATRAJPR.BO) FAQ

The latest EBIT for NATRAJPR.BO is $67M as of June 2026. That compares with $13M in the prior-year period — up 425.7% year over year. That is below the sector sector average of $2.5T. Investors often review this figure alongside Natraj Proteins Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, NATRAJPR.BO's EBIT moved from $13M to $67M — a 425.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Natraj Proteins Limited's operating scale or balance-sheet position.

Against its sector companies, NATRAJPR.BO currently prints $67M for EBIT, while the sector average sits near $2.5T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Natraj Proteins Limited's growth, margins, and balance sheet.

A EBIT figure of $67M for NATRAJPR.BO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.5T. Explore the charts below for those layers of context.

After noting NATRAJPR.BO's EBIT ($67M), review year-over-year change from $13M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.